Personalized, Reprocessed and Refurbished Devices: Definitions Now, Rules Pending

1. Key takeaways

The current Nigerian Regulations treat special device forms on a basis of definitions first, rules to follow:

• Personalized Medical Device — already defined in regulation 51: a device for a specific individual, which may take any of three forms, custom-made, patient-matched or adaptable;
• Reprocessing of Single-Use Medical Device and Refurbishment of Medical devices — the current Regulations contain no dedicated provisions;
• The 2025 draft regulations add §44 Reprocessing of Single-Use Medical Device and §45 Refurbishment of Medical devices in Part 4 (registration), alongside §46 Registration of Establishment and §43 obligations of the holder of the registration certificate.

Key reminder: the 2025 draft had not been gazetted as of the verification date, and the draft provisions do not constitute current obligations.

The practical picture is therefore split. For personalized devices, a company can already act: the definition exists, the mandatory registration duty of guideline §1.2 applies to all devices, and the standard route is the only route until the draft is gazetted. For reprocessing and refurbishment, there is no current rule to follow at all, which makes written confirmation from the Agency the only safe basis for commencing such operations in the Nigerian market.

2. Legal basis

3. Expert insights

Insight 1: the current Regulations give a definition but no pathway — a deliberate gap.

Personalized devices are defined in three forms yet no registration pathway is provided, which means that in practice the standard registration route still applies. However, the characteristic of being made for a specific individual makes standard documentation requirements hard to apply — batch concepts, shelf life and labelling are the obvious friction points. GRZAN’s approach is to file under the standard route while providing NAFDAC a written explanation of the individualized characteristics.

Insight 2: the draft places reprocessing and refurbishment side by side, signaling that the Agency treats them as two distinct matters.

Reprocessing of a single-use medical device refers to reworking a device labelled for single use so that it can be used again; refurbishment refers to repairing and restoring the performance of a device in service. Their risk models differ — the former changes the device’s original compliance status, while the latter changes its service status. Separate provisions in the draft indicate that separate conditions will be set for each in the future.

Insight 3: placing registration of establishment in the same Part signals an extension of regulatory focus from products to entities.

§46 Registration of Establishment sits in Part 4 together with §43 holder obligations and the registration procedures in §32–42, showing that NAFDAC is legislating to bind entity qualification and product registration together. For companies that already operate factories or warehouses in Nigeria, this is a compliance item to prepare for in advance.

Insight 4: Tanzania and Nigeria differ in their approach to refurbishment, a useful lateral reference.

The Tanzanian 2024 consolidated guidelines, Part IV §3.2.3, provide that where refurbished used devices are refurbished by a third party other than the original manufacturer, that third party assumes manufacturer responsibilities — effectively treating the refurbisher as the manufacturer. If the Nigerian draft follows similar logic, refurbishers would face full QMS and registration obligations. This is a lateral reference, not a current Nigerian rule.

Insight 5: the status of the draft must be annotated at every citation.

The draft was published on 23 July 2025, with a public comment period of 60 calendar days, ending on 20 September 2025, with comments to be sent to the official designated mailbox. As of the verification date, no gazetted text has been seen. Any statement that Nigeria has already permitted or prohibited refurbishment must carry the annotation draft and not yet gazetted.

4. Practical recommendations

1. File personalized devices under the standard route, while preparing written explanatory materials on the made-for-a-specific-individual characteristics.
2. Treat reprocessing and refurbishment operations in Nigeria as having no dedicated channel for now, and obtain written confirmation from NAFDAC before commencing.
3. Companies with an established presence in Nigeria should prepare establishment registration materials in advance, in anticipation of draft §46 taking effect.
4. Maintain a draft-tracking mechanism: monitor the Draft Regulations section of the NAFDAC website and gazette publication information.
5. Annotate all draft provisions in external documents as draft and not yet gazetted.

5. Verification checklist

• □ Confirmed whether the product is a Personalized Medical Device (custom-made / patient-matched / adaptable).
• □ Written explanation of the individualized characteristics of personalized devices prepared.
• □ Reprocessing and refurbishment operations confirmed in writing with NAFDAC under the current regulatory position (or listed for confirmation).
• □ Gazettal status of draft §44, §45 and §46 tracked.
• □ All draft provisions in external documents annotated as draft and not yet gazetted.
• □ Entity qualification materials prepared in the direction of establishment registration.

Regulatory information verified as of 29 October 2026. The provisions cited were checked against the regulation text published on the NAFDAC website (S.I. No. 42 of 2024, regulation 51) and the 2025 draft regulations (published 2025-07-23, comment period until 2025-09-20). The draft had not been gazetted as of the verification date.

GRZAN support for the Nigerian market. GRZAN provides NAFDAC registration and compliance support for the Nigerian market, with local resources covering coordination with licensed importers and authorized representative services, NAPAMS online submission, dossier screening permit liaison, import permits, sample delivery and laboratory analysis support. Service capabilities cover classification assessment, registration pathway selection, technical documentation to the IMDRF ToC, CMFS and legalization support, GMP and foreign inspection readiness, advertisement permits, vigilance and PMS reporting, variation management and certificate renewal. Contact: info@grzanglobal.com.